P-327Outcomes according to tumor RAS and BRAF mutation...

Annals of Oncology 2017 / 06 Vol. 28; Iss. suppl_3

P-327Outcomes according to tumor RAS and BRAF mutation status in patients treated with cetuximab in 1st-line treatment of unresectable metastatic colorectal cancer (mCRC): Updated results from EREBUS cohort

Smith, Denis, Sa-cunha, Antonio, Rouyer, Magali, François, Eric, Monnereau, Alain, Yon, Edwige, Bignon, Emmanuelle, Noize, Pernelle, Droz-Perroteau, Cécile, Moore, Nicholas, Fourrier-réglat, Annie
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx261.324
Date:
June, 2017
File:
PDF, 40 KB
english, 2017
Conversion to is in progress
Conversion to is failed